CFTR and cystic fibrosis: In 2017, Altes et al. evaluated the effect of short- and long-term ivacaftor (IVA) treatment on hyperpolarized 3He-MRI in a cohort of CF patients aged ≥12 years with a G551D-CFTR mutation.